- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01278966
Modified Atkins Diet in Children and Adolescents With Drug-resistant Epilepsy
January 17, 2011 updated by: Oslo University Hospital
Modified Atkins Diet in Children and Adolescents With Drug-resistant Epilepsy - a Prospective Pilot Trial
The purpose of the study is to evaluate the effect of the Modified Atkins Diet in children and adolescents with drug-resistant epilepsy regarding seizure control, and to create a protocol for the use of the Modified Atkins Diet as a treatment for epilepsy in Norway.
Study Overview
Detailed Description
The study is a prospective trial on the Modified Atkins Diet for children and adolescents with drug-resistant epilepsy.
The Modified Atkins Diet is a less restrictive diet than the classical ketogenic diet, which is usually offered to this group of patients.
Twenty patients between 2 and 18 years are included in the study, and the study period is 6 months.
The study will be conducted at the National Centre for Child Epilepsy in Norway.
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bærum Postterminal
-
Pb. 53, Bærum Postterminal, Norway, 1306
- The National Centre for Child Epilepsy
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 18 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age: 2-18 years
- At least 3 epileptic seizures per week
- Tried at least two anti-epileptic drugs without satisfactory seizure control
- Willing to try diet treatment for 6 months
Exclusion Criteria:
- Too difficult for the family to adhere to a strict diet
- Not able to fill in a seizure calendar
- Local authorities will not approve the treatment
- VNS stimulator the last 12 months or changes made to VNS stimulator during the last three months
- Other disease where a diet high in fat is contra indicated
- Diet treatment is not possible because of poor intake of food or fluids
- Cortisol or other medication that influence energy metabolism or epileptic drug metabolism last month
- Patient has the last month used alternative medicine which may influence the diet
- Patient has tried the ketogenic fiet og Modified Atkins diet the last three years
- pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: The Modified Atkins Diet
Treatment with the Modified Atkins Diet for 6 months
|
The Modified Atkins Diet; 10 g carbohydrate per day and a high fat intake
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Seizure frequency
Time Frame: 6 months
|
Seizure frequency is assessed after 1 month, 3 months and 6 months.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ambulatory EEG
Time Frame: After 6 months
|
24-hours EEG before diet treatment and after 6 months on the diet.
|
After 6 months
|
Body Weight
Time Frame: 6 months
|
Body weight was measured before diet treatment, after 1 month, 3 months and 6 months.
|
6 months
|
Quality of life
Time Frame: 6 months
|
Questionnaire assessing quality of life and life on a strict diet, assessed after one, three and six months.
|
6 months
|
Ketosis
Time Frame: 6 months
|
Ketosis in blood and urine measured during the whole study period
|
6 months
|
Dietary records
Time Frame: 10 weeks
|
3-days dietary records were obtained after two and ten weeks on the diet.
|
10 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Morten Lossius, Phd, Oslo University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2009
Primary Completion (ACTUAL)
December 1, 2010
Study Completion (ACTUAL)
December 1, 2010
Study Registration Dates
First Submitted
December 29, 2010
First Submitted That Met QC Criteria
January 17, 2011
First Posted (ESTIMATE)
January 19, 2011
Study Record Updates
Last Update Posted (ESTIMATE)
January 19, 2011
Last Update Submitted That Met QC Criteria
January 17, 2011
Last Verified
December 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- S-09180a (REK)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epilepsy
-
NaviFUS CorporationTaipei Veterans General Hospital, TaiwanCompletedDrug Resistant Epilepsy | Epilepsy, Drug Resistant | Intractable Epilepsy | Refractory Epilepsy | Drug Refractory Epilepsy | Epilepsy, Drug Refractory | Epilepsy, Intractable | Medication Resistant EpilepsyTaiwan
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
University of British ColumbiaTerminatedJuvenile Myoclonic Epilepsy | Childhood Absence Epilepsy | Juvenile Absence EpilepsyCanada
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Neuroelectrics CorporationRecruitingEpilepsy | Seizures | Refractory Epilepsy | Epilepsy, Tonic-Clonic | Epilepsy in Children | Seizures, Focal | Focal SeizureSpain, United States, France, Belgium
-
Oslo University HospitalCompletedEpilepsy | Generalized Epilepsy | Focal EpilepsyNorway
-
UCB Pharma SACompletedEpilepsy, Tonic-clonicPoland, Sweden, Hungary, Czechia
-
UCB PharmaCompletedEpilepsy, Tonic-clonic
-
University Hospital, LilleUnknownFocal Epilepsy | Epilepsy IntractableFrance
-
Xuanwu Hospital, BeijingPeking University; Beijing Tiantan Hospital; Qilu Hospital of Shandong University and other collaboratorsNot yet recruitingEpilepsy, Drug ResistantChina
Clinical Trials on The Modified Atkins Diet
-
University of Wisconsin, MadisonNational Institutes of Health (NIH); Wisconsin Institute for Clinical and Translational...SuspendedEpilepsy | SeizuresUnited States
-
Johns Hopkins UniversityVascular Birthmarks FoundationCompletedEpilepsy | Sturge Weber SyndromeUnited States
-
Johns Hopkins UniversityCompleted
-
Johns Hopkins UniversityTerminated
-
Johns Hopkins UniversityCompleted
-
Hugo W. Moser Research Institute at Kennedy Krieger...Active, not recruiting
-
University of VirginiaCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Hadassah Medical OrganizationCompletedObese Type 2 Diabetic Patients
-
Loma Linda UniversityEnrolling by invitationTraumatic Brain InjuryUnited States
-
Johns Hopkins UniversityEnrolling by invitationEpilepsy | Coronary Disease | Cardiovascular Disease | Hypercholesterolemia | Heart Disease | Cerebrovascular Disease | Seizure | Carotid Intimal Medial Thickness 1United States